We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 2010
Jeyes is to relocate up to 80 head office staff from its cleaning products production site in Thetford to a new office on the Cambridge Business Park in March.
Aesica has acquired three pharmaceutical manufacturing plants in Germany and Italy from UCB, which will double the total size of its Newcastle-based business.
PsiOxus Therapeutics has announced the formation of a new Oxfordshire-based biotechnology group from the merger of Myotec Therapeutics with Hybrid Biosystems.
Reckitt Benckiser is to acquire Paras Pharmaceuticals, the Indian supplier of over-the-counter medicines with 700 staff, for £460m.
Yule Catto is to acquire PolymerLatex, the German manufacturer of emulsion polymer products, for £376m.
GRI Group has acquired Libra Chemicals, the Manchester-based chemicals manufacturer with 35 staff, and plans to double the size of the business by 2013.
GlaxoSmithKline is to acquire Nanjing MeiRui Pharma Co, the Chinese pharmaceuticals manufacturer, for £44m.
Axis-Shield is to acquire the global clinical chemistry homocysteine operations of US-based Catch Incorporated for £6.3m.
Sinclair Pharma has acquired Cranage Healthcare, the Cheshire-based distributor of woundcare products, for an initial £0.4m.
Biotec Services International, the Bridgend-based pharmaceutical services firm, has undergone a management buy-out for undisclosed terms.
PolyBlend, the polymer manufacturer, has acquired a 27,000 sq ft manufacturing and warehouse site on Everite Road in Widnes.
EKF Diagnostics has acquired Argutus Medical, the Irish developer of novel biomarkers of organ injury, for £2.2m.
United Drug has acquired World Events Group, the provider of event management and marketing services to pharmaceutical manufacturers with more than 100 staff, for £13m.
Source BioScience has acquired ImaGenes, the German supplier of genomic products for manipulating gene and protein function, for £2m.
Dechra Pharmaceuticals has acquired Genitrix, the Billingshurst-based veterinary pharmaceuticals company, for an initial £5.4m.
GlaxoSmithKline is planning to create up to 1,000 new jobs in the UK, following research tax breaks that will enable it to invest £500m in the expansion of a factory in Hertfordshire and a new biopharmaceuticals plant.
Rivington Street Holdings is to acquire Quartzsite Medical and Biostability, in order to expand its new Isle of Man-based Athol Street Pharmaceuticals subsidiary.
Eden Biodesign is looking to expand the 90-strong workforce at its biopharmaceuticals plant in Speke with 35 new staff over the next few months.
Aurelius of Germany has acquired a chemical production complex in Grangemouth from KemFine for undisclosed terms, with the transfer of up to 200 staff.
BTG is to acquire Biocompatibles, the Farnham-based supplier of drug devices, for £156m.
Grosvenor Chemicals is seeking permission from Kirklees Council to rebuild the storage, office and laboratory facilities at its site in Linthwaite, following a recent fire.
Almac Group is continuing to recruit new staff at its pharmaceutical research and development operations in Northern Ireland, and currently has 100 vacancies across the group.
Reinnervate is planning to create 30 new jobs at its life sciences technology business in Sedgefield next year.
Omega Diagnostics is to acquire the in-vitro diagnostics division of Allergopharma Joachim Ganzer of Germany for £5m, with the transfer of 29 staff.
BioInnovel, the developer of bioprocess monitoring technologies, is to take space at the Innovation Accelerator Incubator laboratory being built at the Wilton Centre on Teesside.
Gen-Probe, the US biotechnology company, is to set up a £5m European headquarters in Manchester, extending its current site in Wythenshawe from 11,000 sq ft to 60,000 sq ft and creating 35 new jobs by 2012.
Monitor Coatings has secured £0.4m from the North-East Growth Fund to help expand its Tyneside-based industrial coatings business, including new equipment and an increase to the 34-strong workforce.
Huntsman Corporation is to invest £3.5m in the expansion of production at its amines plant in Llanelli, securing the future of 46 jobs.
Sanofi Aventis has sold its pharmaceuticals plant in Alnwick to Covance of the US, with the transfer of 140 staff.
Mitsubishi Chemical Corporation is to build a new £20m plant in Billingham to manufacture electrolytes for electric vehicle batteries by the end of next year.
Vickers Laboratories, the Leeds-based distributor of speciality chemicals with 22 staff, has undergone a management buy-out for undisclosed terms.
Dechra Pharmaceuticals is to acquire DermaPet, the US supplier of dermatological preparations for animals, for £40m.
Dow Chemical is to set up a supply chain design centre in Belfast, with the creation of 25 jobs.
The European Medicines Evaluation Agency (EMEA) has shortlisted five potential sites in east London for a new 300,000 sq ft office.
Johnson Matthey is to acquire Intercat, the US supplier of fluid catalytic cracking additives with 180 staff, for £35m.
Biocatalysts has announced plans to expand the 40-strong workforce at its enzyme manufacturing business near Caerphilly with 25 new jobs over the next five years.
Huntsman is to sell its EA West water treatment chemicals business to Industrial Chemicals, with the possible loss of 12 jobs in Grimsby.
Unilever is to acquire Alberto Culver, the US-based supplier of hair care and skin care products with 2,700 staff in nine countries, for £2.3bn.
PZ Cussons has acquired St Tropez Holdings, the supplier of sunless tanning products, from private equity firm LDC for £62m.
EKF Diagnostics is to acquire Quotient Diagnostics, the Surrey-based developer of diabetes monitoring devices, for an initial £3.4m.
ValiRx is to sell ValiBIO, its Belgian diagnostics subsidiary, to Singapore Volition for £0.6m.
Croda is planning a further multi-million pound investment at its polymer additives production plant in Hull.
Exwold Technology has secured a £1m investment to expand its chemicals manufacturing operations in Hartlepool and Billingham, including a new compaction plant and an increase to the 60-strong workforce.
Animalcare has confirmed the sale of its Fearing International and Ritchey agricultural operations to Tru-Test UK for £3.2m, in order to focus on veterinary medicines.
KemFine UK has been acquired by Aurelius of Germany for undisclosed terms, securing the future of up to 200 jobs at its chemicals production business in Grangemouth.
NeutraHealth, the Birmingham-based vitamins supplier, is to be acquired by Elder Pharmaceuticals of India for £12m.
Animalcare, the supplier of veterinary medicines, is in negotiations to sell its Fearing International and Ritchey agricultural operations.
Immunodiagnostic Systems has acquired MGP Diagnostics of Norway for undisclosed terms.
Thornton & Ross has acquired the Allens herbal remedies brand of Anglesey-based Allens & Co.
Corridor Manchester has selected a consortium of Bruntwood and Manchester Science Parks to develop a £21m biomedical research centre at the former Manchester Royal Eye Hospital by summer 2012, which will create 440 jobs.
McBride has acquired a 70% stake in Dermacol, the Czech manufacturer of skincare products with more than 100 staff, for £8m.
Warwick International is to sell its speciality chemicals distribution business, which has annual sales of £66m, to IMCD Group of the Netherlands.
The University of Edinburgh has secured a £10m donation to set up a new research clinic for multiple sclerosis.
ImmunoSolv of Edinburgh has merged with Grampian BioConsultants of Aberdeen for undisclosed terms, having secured additional funding from Grampian BioPartners and Scottish Enterprise.
MedImmune, the biologics division of AstraZeneca, is setting up a new 22,000 sq ft office at Granta Park in Cambridge.
Aesica is to build a new £3m pharmaceutical production facility at its Queenborough site in Kent by May 2011.
Polar Speed Distribution is to relocate its Leicestershire-based pharmaceuticals business and 20 staff to a smaller site in Swadlincote, Derbyshire.
United Drug has acquired InforMed Group, the Macclesfield-based healthcare communications consultancy with 80 staff, for £11m.
Cyprotex has acquired Apredica, the US pharmaceuticals research firm, for £2.7m.
Selby District Council has approved plans from Sedacol UK to develop a processing plant to produce distilled alcohol at the former Tate & Lyle site in Selby, with the creation of 50 jobs.
LGC Standards is to relocate its Bury-based testing laboratory and 45 staff to a 19,500 sq ft site on Carlyle Street in November.
M&A Pharmachem, the pharmaceuticals supplier, has acquired the 40,000 sq ft former Newsquest printing plant at Wingates Industrial Park in Bolton for £2m.
Cyprotex is to double the capacity at its pharmaceutical testing laboratory in Macclesfield, with the creation of ten jobs.
FPCi is looking to expand the 65-strong workforce at its Stokesley-based organic chemicals and automotive components manufacturing business to 120 over the next two years.
Allergy Therapeutics is to acquire Teomed, the Swiss pharmaceuticals distributor with 12 staff, for £0.7m.
Aesica has acquired R5 Pharmaceuticals, the Nottingham-based pharmaceuticals manufacturer with 51 staff, for undisclosed terms.
Quintiles, the US pharmaceuticals firm, is to relocate its UK headquarters from Bracknell to a 120,000 sq ft office at Green Park in Reading.
Ineos Bio has unveiled plans to build a £52m waste-fuelled bioethanol plant at its Seal Sands site on Teesside by 2015, with the creation of 40 jobs.
Mentholatum has announced a multi-million pound investment in the expansion of its skin care products factory in East Kilbride, with the creation of 20 jobs.
GlaxoSmithKline has acquired Laboratorios Phoenix, the Argentinian pharmaceuticals company, for £172m.
Quay Pharma is creating 65 jobs at a new £2.7m pharmaceuticals research and development facility at Deeside in North Wales.
LGC Group is planning to upgrade the facilities at its forensic laboratory at Risley near Warrington, and 40 staff will relocate from its site in Runcorn.
Respivert, the London-based drug discovery company, has been sold by Imperial Innovations to Centocor Ortho Biotech for £9.5m.
Martindale Pharmaceuticals has been sold by Cardinal Health to private equity firm AAC Capital for about £100m.
The Wilton Centre on Teesside is to start work on the development of a 10,000 sq ft Innovation Accelerator Incubator, which will create up to 100 jobs at ten new laboratory units.
TPP Global Development is to set up a headquarters for its new life sciences business at the Edinburgh BioQuarter, with the creation of an initial 15 jobs.
Celgene is said to be considering plans to relocate its pharmaceuticals business from Windsor to a 50,000 sq ft office at Stockley Park in West London.
Paragon Inks is to relocate its Broxburn-based printing inks business and 37 staff to a new £3.5m headquarters at Starlaw Park near Bathgate in November.
Bio-D, the Hull-based developer of environmentally-friendly cleaning products, has undergone a management buy-out.
Croda is to sell its oleochemicals production site at Emmerich in Germany to KLK Group for £55m.
ZooBiotic of Bridgend has acquired BioMonde of Germany for undisclosed terms, creating a combined wound healing group with annual sales of £5m.
Bayer is investing £10m in improvements to its crop chemicals site in Norwich, securing the future of 280 jobs.
The University of Leicester is planning to build a new £15m drug testing laboratory by early 2011.
Randox Laboratories is to continue to expand the 850-strong workforce at its Crumlin-based medical diagnostics business over the coming months.
Warner Chilcott has announced a £6.6m investment in the expansion of its pharmaceuticals research facility in Larne, supported by £1.7m from Invest NI.
University of Aberdeen has secured £2.6m of European funding to develop a £5.8m life sciences business centre, with the creation of 69 jobs.
Novartis is hoping to win government support to upgrade its vaccines plant in Speke within five years, in order to secure the future of 750 jobs.
Apex Speciality Solutions is looking to expand the 40-strong workforce at its Aberdeen-based chemicals distribution business with about ten new jobs.
Intertek has acquired Ciba Expert Services, the Swiss pharmaceutical and chemical safety testing firm with 200 staff and an office in Macclesfield, from BASF for undisclosed terms.
Colony Gift Corporation, the manufacturer of home fragrance products with about 170 staff, is to invest £1m in the expansion of its factory in Ulverston over the next year.
Medical Research Council has secured £250m of government funding to develop a biomedical science research laboratory at St Pancras in London by 2015.
Avon has acquired Liz Earle Beauty, the Isle of Wight-based skincare firm with 300 staff, for undisclosed terms.
Industrial Chemicals has acquired a 35-acre chemical production site in Selby from Clariant Production for undisclosed terms, and will use it as an additional manufacturing facility.
Irish Salt Mining & Exploration has won approval to extend its salt mine near Carrickfergus, securing 54 jobs and creating up to ten new jobs.
Polartech, the Manchester-based supplier of chemicals to the metalworking industry with 130 staff, has been acquired by Afton Chemical Corporation of the US for undisclosed terms.
Centre for Process Innovation is to create up to 40 jobs at a new £12m industrial biotechnology testing centre due to open at Wilton on Teesside later this year.
Membrane Extraction Technology, the London-based chemical separation products supplier, has been acquired by Evonik Industries of Germany for about £4m.
Hallam Beauty, the Bradford-based manufacturer of personal care products, has been acquired by Mibelle for undisclosed terms.
Alliance Boots is creating 50 jobs at its new BCM Specials bespoke medicines laboratory in Nottingham.
Stemgent of the US is to invest £3m in the development of a new cancer drugs research facility called Ubiquigent in Dundee over the next three years.
Avacta has acquired Reactivlab, the Glasgow-based veterinary diagnostics firm, for up to £5m.
Deb Group, the skincare and cleaning products manufacturer with 220 staff in Derbyshire, has undergone a £325m management buy-out backed by Charterhouse Capital.
ApaTech, the Hertfordshire-based synthetic bone developer, is to be acquired by Baxter International of the US for up to £222m.
Plant Impact has raised £2m in a share placing to fund the expansion of its Preston-based organic fertilisers business, including the recruitment of new sales and marketing staff.
Leeds Skin Care is relocating its skincare laboratory service from the University of Leeds to the Sandbeck Lane industrial estate in Wetherby.
Koch Fertilizer Trading has reached agreement with the Bristol Port Company to add a further 25,000 tonnes of storage capacity at its fertiliser terminal in Avonmouth by the end of the year.
GlaxoSmithKline is looking to create 1,000 new jobs in the UK, as part of a £500m investment in the life sciences sector that follows a government decision to cut taxes on revenues from patents.
Genzyme is to expand its life sciences research facility at Cambridge Science Park with an additional 10,000 sq ft of laboratory and office space.
Excelsyn, the North Wales-based provider of manufacturing services to pharmaceutical companies with 60 staff, has been acquired by Albany Molecular Research of the US for £12m.
Ineos, the chemicals manufacturer, has won approval from the National Park Authority to build a new office for up to 150 staff at Lyndhurst in the New Forest.
Travik Chemicals is planning to relocate its speciality chemical manufacturing business from County Durham to Tockwith near York.
KemFine, the agricultural chemicals manufacturer with about 460 staff in Grangemouth and Finland, is expected to be put up for sale by private equity owner 3i.
Oxford Nutrascience has raised £1.1m in an initial public offering to fund the commercial development of its tablets and syrups.
GlaxoSmithKline is planning to relocate more than 40 nutritional healthcare research jobs from Coleford to Brentford later this year, and a similar number of jobs will relocate from its site in Slough.
Vernalis has raised £25m in a share placing to fund the expansion of its pharmaceuticals research business.
Glide Pharma of Didcot has secured a further £2.7m of venture capital to fund the commercial development of needle-free drug delivery systems.
Fillcare is to invest £7m in the expansion of the former L'Oreal cosmetics factory in Llantrisant, with the creation of almost 200 jobs over the next four years.
Alliance Pharma is to acquire the trade and assets of Cambridge Laboratories for up to £16m, with the transfer of about 30 staff in Newcastle and Dublin.
LGC, the forensic research group with 1,500 staff at 28 biological and chemical laboratories, is to be acquired by Bridgepoint for £257m.
Ineos Fluor is to sell its Runcorn-based fluorochemicals business to Mexichem of Mexico for an estimated £220m, with the transfer of about 280 staff.
Anglian Chemicals has been bought out of administration by a former owner, securing 25 jobs at its cleaning chemicals manufacturing business in Fakenham.
Angel Biotechnology has raised £1.4m in a share placing to fund the expansion of capacity at its facility in Edinburgh.
Thompson & Morgan has acquired Chempak, the Ipswich-based supplier of plant foods, for undisclosed terms.
Crown Paints has secured a £25m funding package to invest in expansion opportunities for its Lancashire-based paint manufacturing business.
ICI-Imagedata, the coatings manufacturer with 50 staff, has been acquired by Illinois Tool Works of the US for undisclosed terms.
Lotte Chemical UK is to acquire two PTA and PET chemical plants at Wilton on Teesside from the administrators of Artenius UK, which will save 41 jobs and create up to 132 new jobs.
The Biotechnology & Biological Sciences Research Council (BBSRC) is to open new laboratory and office facilities for up to 300 research scientists at Norwich Research Park this summer.
Randox Laboratories is planning to create 23 new jobs at its diagnostic test products business in County Antrim.
International Paint is to invest £6.4m in a new fire protection products testing laboratory at its site in Gateshead by 2011, with the creation of 14 jobs.
AstraZeneca is said to be planning to set up a 55,000 sq ft office at Stockley Park near Heathrow.
Cleveland Potash has unveiled proposals to set up a nationwide network of salt depots, in order to help local authorities with road gritting in winter.
Waymade Healthcare is planning to expand the 14-strong workforce at its new £1m pharmaceuticals factory in Basildon to 28 by the end of the year.
Vireol is linking up with Future Capital Partners and Simon Carves to proceed with plans for the development of a £236m bioethanol plant in Grimsby, which will create more than 50 jobs.
Proximagen Neuroscience is to acquire Minster Pharmaceuticals, the London-based drug development company, for £4.3m.